The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998
Open accessAbstract
BACKGROUND The guidelines on chemotherapy and management of tuberculosis in the United Kingdom have been reviewed and updated. METHODS A subcommittee was appointed by the Joint Tuberculosis Committee (JTC) of the British Thoracic Society to revise the guidelines published in 1990 by the JTC. In preparing the revised guidelines the authors took account of new published evidence and graded the strength of evidence for their recommendations. The guidelines have been approved by the JTC and the Standards of Care Committee of the British Thoracic Society. RECOMMENDATIONS (1) Patients with tuberculosis should be notified. (2) In view of the rising incidence of drug resistance, bacteriological confirmation and drug susceptibility testing should be sought whenever possible. (3) A six month short course regimen, with four drugs in the initial phase, should be used for all forms of tuberculosis, except meningitis, in both adults and children. (4) The fourth drug (ethambutol) in the initial phase can be omitted in certain circumstances. (5) Treatment of all patients should be supervised by physicians with full training in the management of tuberculosis and with direct working access to tuberculosis nurse specialists or health visitors. (6) Advice is given on (a) management in special situations and patient groups, (b) drug interactions, and special precautions and pretreatment screening, (c) chemoprophylaxis for different groups, and (d) the management of single and multiple drug resistance. (7) Advice is given on follow up after treatment and the organisational framework for tuberculosis services. (8) The role of directly observed therapy is discussed. (9) The management of multidrug resistant tuberculosis is explained in outline: such patients should be managed by physicians with special experience and in close liaison with the Mycobacterium Reference Units, and in hospitals with appropriate isolation facilities. (10) Infection control and segregation for such patients and for patients with dual infection with human immunodeficiency virus (HIV) and tuberculosis are covered in an .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, this approach has not been shown to be better than assessing for clinical symptoms of hepatitis at detecting toxicity.181–184”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [184]
In the citing paper
“Although the incidence of severe DILI appears to be lower than previously appreciated,180 isoniazid continues to be a leading cause of DILI‐related ALF in the United States and worldwide (Table 2).181–184”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [184]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Red Book: 2024–2027 Report of the Committee on Infectious Diseases
Committee on Infectious Diseases, A. A. O. P. (2024) · doi:10.1542/9781610027359 · Cited by 1,548
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
Telenti, A., Imboden, P., Marchesi, F., Matter, L., Schopfer, K., Bodmer, T., Lowrie, D., Colston, M. J., & Cole, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)90417-f · Cited by 1,337
Bass, J. B., Farer, L. S., Hopewell, P. C., O'Brien, R., Jacobs, R. F., Ruben, F., Snider, D. E., & Thornton, G. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.5.8173779 · Cited by 1,193
Controlled chemoprophylaxis trials in tuberculosis. A general review.
Sh, F. (1970) · PubMed · Cited by 721
Treatment of Multidrug-Resistant Tuberculosis
Wood, A. J. J., & Iseman, M. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309093291108 · Cited by 706
Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and Rifampin
Goble, M., Iseman, M. D., Madsen, L. A., Waite, D., Ackerson, L., & Horsburgh, C. R. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280802 · Cited by 698
Iuat (1982) · Bulletin of the World Health Organization · Cited by 515
The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
Jindani, A., Aber, V. R., Edwards, E. A., & Mitchison, D. A. (1980) · PubMed · doi:10.1164/arrd.1980.121.6.939 · Cited by 487
Treatment of Tuberculosis in Patients with Advanced Human Immunodeficiency Virus Infection
Small, P. M., Schecter, G. F., Goodman, P. C., Sande, M. A., Chaisson, R. E., & Hopewell, P. C. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101313240503 · Cited by 477
When Tuberculosis Treatment Fails: A Social Behavioral Account of Patient Adherence
Sumartojo, E. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1311 · Cited by 468
Control and prevention of tuberculosis in the United Kingdom: Code of Practice 2000
Joint Tuberculosis Committee of the British Thoracic Society (2000) · Thorax · doi:10.1136/thorax.55.11.887 · Cited by 366
Self-citationRisk factors for acute myocardial infarction in Indians: a case-control study
Pais, P., Pogue, J., Gerstein, H., Zachariah, E., Savitha, D., Jayprakash, S., Nayak, P., & Yusuf, S. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02507-x · Cited by 320
Transmission of tubercle bacilli: The effects of chemotherapy
Rouillon, A., Perdrizet, S., & Parrot, R. (1976) · Tubercle · doi:10.1016/s0041-3879(76)80006-2 · Cited by 310
Immunisation against infectious disease.
Citron, K. M., & Lunn, J. A. (1988) · BMJ · doi:10.1136/bmj.297.6660.1406 · Cited by 308
Hong Kong Chest Service/Tuberculosis Research Centre, M. M. R. C. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.1.36 · Cited by 304
Schoeman, J. F., Van Zyl, L. E., Laubscher, J. A., & Donald, P. R. (1997) · Pediatrics · doi:10.1542/peds.99.2.226 · Cited by 300
Mitchison, D. A., & Nunn, A. (1986) · PubMed · doi:10.1164/arrd.1986.133.3.423 · Cited by 291
Treatment of Tuberculosis and Tuberculosis Infection in Adults and Children
Ad Hoc Committee of the Scientific Assembly on Microbiology, T. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.1.9 · Cited by 262
Maldhure, B. R., Munje, R. P., Zodpey, S. P., et al. (1997) · Lung India · Cited by 260
Crossley, P. E. L. (1954) · International Journal of Dairy Technology · doi:10.1111/j.1471-0307.1954.tb00809.x · Cited by 259
Strang, J. I. G., Gibson, D. G., Mitchison, D. A., Girling, D. J., Kakaza, H. H. S., Allen, B. W., Evans, D. J., Nunn, A. J., & Fox, W. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92415-4 · Cited by 227
Drug Interactions with Fluconazole
Lazar, J. D., & Wilner, K. D. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.supplement_3.s327 · Cited by 225
Strang, J. I. G., Gibson, D. G., Nunn, A. J., Kakaza, H. H. S., Girling, D. J., & Fox, W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91127-5 · Cited by 218
CHANGES IN CORTISOL METABOLISM FOLLOWING RIFAMPICIN THERAPY
Edwards, O., Galley, J. M., Courtenay-Evans, R. J., Hunter, J., & Tait, A. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91876-5 · Cited by 209
Ackah, A. N., Digbeu, H., Daillo, K., Greenberg, A. E., Coulibaly, D., Coulibaly, I.-M., Vetter, K. M., & de Cock, K. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90519-7 · Cited by 208
Lymph node tuberculosis: A comparison of various methods of treatment
Campbell, I. A., & Dyson, A. J. (1977) · Tubercle · doi:10.1016/0041-3879(77)90041-1 · Cited by 189
Gordin, F. M., Matts, J. P., Miller, C., Brown, L. S., Hafner, R., John, S. L., Klein, M., Vaughn, A., Besch, C. L., Perez, G., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370505 · Cited by 166
Control of tuberculosis by community health workers in Bangladesh
Chowdhury, A. M. R., Chowdhury, S., Islam, M. N., Islam, A., & Vaughan, J. P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11311-8 · Cited by 164
Corticosteroids in the Treatment of Tuberculous Pleurisy
Lee, C.-H., Wang, W.-J., Rs, L., Tsai, Y., & Chiang, Y.-C. (1988) · CHEST Journal · doi:10.1378/chest.94.6.1256 · Cited by 155
China Tuberculosis Control Collaboration (1996) · The Lancet · doi:10.1016/s0140-6736(96)90537-1 · Cited by 138
Interaction of Ketoconazole with Rifampin and Isoniazid
Engelhard, D., Stutman, H. R., & Marks, M. I. (1984) · New England Journal of Medicine · doi:10.1056/nejm198412273112606 · Cited by 122
McGregor, M. M., Olliaro, P., Wolmarans, L., Mabuza, B., Bredell, M., Felten, M. K., & Fourie, P. B. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.5.8912765 · Cited by 101
Girling, D. J., Darbyshire, J. H., Humphries, M. J., & Mahoney, G. O. (1988) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072280 · Cited by 94
Ocular toxicity from ethambutol.
Citron, K. M., & Thomas, G. (1986) · Thorax · doi:10.1136/thx.41.10.737 · Cited by 92
Six months versus nine months chemotherapy for tuberculosis of lymph nodes: Final results
Campbell, I. A., Ormerod, L. P., Friend, J. A. R., Jenkins, P. A., & Prescott, R. J. (1993) · Respiratory Medicine · doi:10.1016/s0954-6111(05)80265-3 · Cited by 87
Gauthier, M. (1996) · Critical Care Medicine · doi:10.1097/00003246-199605000-00040 · Cited by 73
Hepatotoxicity of antituberculosis drugs.
Ormerod, L. P., Skinner, C., & Wales, J. K. (1996) · Thorax · doi:10.1136/thx.51.2.111 · Cited by 72
Cerebrospinal fluid concentrations of ethionamide in children with tuberculous meningitis
DONALD, P. R., & Seifart, H. I. (1989) · The Journal of Pediatrics · doi:10.1016/s0022-3476(89)80862-5 · Cited by 69
Penetration of pyrazinamide into the cerebrospinal fluid in tuberculous meningitis.
Ellard, G. A., Humphries, M. J., Gabriel, M., & Teoh, R. (1987) · BMJ · doi:10.1136/bmj.294.6567.284 · Cited by 66
Comprehensive Tuberculosis Control for Patients at High Risk for Noncompliance
Schluger, N. W., Ciotoli, C., Cohen, D. A., Johnson, H., & Rom, W. N. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.5.7735604 · Cited by 64
Pulmonary tuberculosis in HIV-infected patients in Zaire
Jh, P. (1996) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(96)85104-3 · Cited by 51
Crofton, J. (1960) · BMJ · doi:10.1136/bmj.2.5196.449 · Cited by 47
Directly observed therapy for tuberculosis
Morse, D. I. (1996) · BMJ · doi:10.1136/bmj.312.7033.719 · Cited by 40
Heylen, R. M., & Miller, R. F. (1996) · Sexually Transmitted Infections · doi:10.1136/sti.72.4.237 · Cited by 36
Lymph node tuberculosis: A comparison of treatments 18 months after completion of chemotherapy
Campbell, I. A., & Dyson, A. J. (1979) · Tubercle · doi:10.1016/0041-3879(79)90042-4 · Cited by 34
Geiter, L. J., O'Brien, R. J., Combs, D. L., & Snider, D. E. (1987) · Tubercle · doi:10.1016/s0041-3879(87)80021-1 · Cited by 29
Six-months versus nine-months chemotherapy for tuberculosis of lymphnodes: preliminary results
British Thoracic Society Research Committee (1992) · Respiratory Medicine · doi:10.1016/s0954-6111(06)80142-3 · Cited by 28
Molecular biology in the diagnosis and epidemiology of tuberculosis
Drobniewski, F. A., Kent, R., Stoker, N. G., & Uttley, A. H. C. (1994) · Journal of Hospital Infection · doi:10.1016/0195-6701(94)90089-2 · Cited by 21
The downside of isoniazid chemoprophylaxis
FitzGerald, J. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90397-6 · Cited by 15
The Management of Lymph Node Tuberculosis Notified in England and Wales in 1993
Ormerod, L. P., & Bentley, C. (1997) · Journal of the Royal College of Physicians of London · doi:10.1016/s0035-8819(25)00091-1 · Cited by 9
Cited by
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.supplement_3.ats600 · Cited by 1,241
Palomino, J.-C., Martin, A., Camacho, M., Guerra, H., Swings, J., & Portaels, F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2720-2722.2002 · Cited by 1,229
Antituberculosis drug‐induced hepatotoxicity: Concise up‐to‐date review
Tostmann, A., Boeree, M. J., Aarnoutse, R. E., De Lange, W. C. M., Van Der Ven, A. J. A. M., & Dekhuijzen, R. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05207.x · Cited by 781
Garg, R. K., & Somvanshi, D. S. (2011) · The Journal of Spinal Cord Medicine · doi:10.1179/2045772311y.0000000023 · Cited by 779
Frieden, T. R., Sterling, T. R., Munsiff, S. S., Watt, C. J., & Dye, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14333-4 · Cited by 689
Metadata
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.